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Resistance to paracoccidioidomycosis, the most important endemic mycosis in Latin America, is thought to
be primarily mediated by cellular immunity and the production of gamma interferon. To assess the role of
interleukin-4 (IL-4), a Th2 cytokine, pulmonary paracoccidioidomycosis in IL-4-depleted susceptible (B10.A)
and intermediate (C57BL/6) mice was studied. Two different protocols were used to neutralize endogenous IL-4
in B10.A mice: 1 mg of anti-IL-4 monoclonal antibody (MAb)/week and 8 mg 1 day before intratracheal
infection with 106 Paracoccidioides brasiliensis yeast cells. Unexpectedly, both protocols enhanced pulmonary
infection but did not alter the levels of pulmonary cytokines and specific antibodies. Since in a previous work
it was verified that C57BL/6 mice genetically deficient in IL-4 were more resistant to P. brasiliensis infection,
we also investigated the effect of IL-4 depletion in this mouse strain. Treatment with the MAb at 1 mg/week led
to less severe pulmonary disease associated with impaired synthesis of Th2 cytokines in the lungs and liver of
control C57BL/6 mice. Conversely, in IL-4-depleted C57BL/6 mice, increased levels of tumor necrosis factor
alpha and IL-12 were found in the lungs and liver, respectively. In addition, higher levels of immunoglobulin
G2a (IgG2a) and lower levels of IgG1 antibodies were produced by IL-4-depleted mice than by control mice.
Lung pathologic findings were equivalent in IL-4-depleted and untreated B10.A mice. In IL-4-depleted
C57BL/6 mice, however, smaller and well-organized granulomas replaced the more extensive lesions that
developed in untreated mice. These results clearly showed that IL-4 can have a protective or a disease-
promoting effect in pulmonary paracoccidioidomycosis depending on the genetic background of the host.
An isogenic murine model of paracoccidioidomycosis
(PCM), the most important endemic mycosis of Latin Amer-
ica, was developed. In this model, B10.A mice were susceptible
and A/Sn mice were resistant to intraperitoneal (i.p.) Paracoc-
cidioides brasiliensis infection (12). Infections in these mouse
strains mimicked the polar forms of the disease. Anergy of
delayed-type hypersensitivity reactions, elevated production of
immunoglobulin G1 (IgG1) and IgG2b antibodies, impaired
macrophage activation, and progressive infection were the
main features of P. brasiliensis-infected B10.A mice. The im-
mune response of resistant A/Sn mice was characterized by the
preferential production of IgG2a antibodies, the presence of
delayed-type hypersensitivity reactions, and efficient macro-
phage activation (10, 11). When infected by the intratracheal
(i.t.) route, which better mimics human pulmonary disease,
B10.A and A/Sn mice sustained their progressive and regres-
sive patterns of disease, respectively (17).
Cytokine measurements in the i.p. model of infection
showed preferential and sustained secretion of gamma inter-
feron (IFN-) and interleukin-2 (IL-2) by antigen-stimulated
lymphocytes from A/Sn mice. Although a typical Th2 pattern
was not found, the absence of IFN- production characterized
the secretion pattern of B10.A lymphocytes (9, 26). In the
pulmonary model, both mouse strains secreted IFN-, IL-2,
IL-4, IL-5, and IL-10 in the lungs, but these mediators ap-
peared in larger amounts in B10.A mice than in A/SN mice
(15, 16). Accordingly, in vivo depletion of IFN- was shown to
exacerbate pulmonary disease in both susceptible and resistant
mice (16). Furthermore, IFN- gene knockout C57BL/6 mice
developed extremely severe and disseminated PCM, with non-
organized granulomas and precocious death of animals (46). It
was also verified that the administration of recombinant IL-12
was protective for susceptible mice that showed decreased
dissemination of yeasts to the liver and spleen but a marked
inflammatory reaction in the lungs (2).
IL-4 is an immunoregulatory cytokine produced by Th2 lym-
phocytes, mast cells, basophils, and a subpopulation of NK
lymphocytes (1). IL-4 induces the differentiation of naive T
cells into Th2 lymphocytes, regulates the switch of B cells to
IgE-secreting cells, and is involved in immediate-type hyper-
sensitivity inflammatory reactions (28, 42). In contrast, IL-4
inhibits IFN- production and suppresses IFN--mediated
macrophage activation (22, 49). For several facultative or
obligatory intracellular pathogens, the neutralization of endog-
enous IL-4 leads to the immunoprotection of susceptible hosts
and allows the development of Th1 rather Th2 immune re-
sponses (23, 29, 34, 39, 40).
The severity of human PCM was found to correlate with the
host’s propensity to mount a Th2 immune response character-
ized by the secretion of high levels of IL-4, IL-5, and IL-10, the
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presence of blood eosinophilia, and the secretion of IgG4- and
IgE-specific antibodies (3, 30, 37). In addition, the secretion of
IFN- was found to be impaired in patients with the active
disease (5, 25, 37).
Earlier work showed that IL-4-deficient C57BL/6 mice were
more resistant to P. brasiliensis infection than their non-IL-4-
deficient counterparts. Compared with wild-type controls, IL-
4-deficient mice had lower pulmonary and hepatic fungal
counts, decreased production of Th2 cytokines (IL-5 and IL-
10), increased secretion of IFN-, and smaller and better or-
ganized granulomas (38). In the present study, we examined
whether IL-4 is an endogenous mediator of susceptibility to P.
brasiliensis infection by comparing the severity of pulmonary
PCM in IL-4-depleted and untreated susceptible (B10.A)
mice. A specific monoclonal antibody (MAb) (11B11) was used
in two experimental protocols to deplete endogenous IL-4
from susceptible mice. We also examined whether in vivo de-
pletion of IL-4 from C57BL/6 mice would lead to less severe
PCM like that developed by C57BL/6 mice with a homozygous
deletion of the IL-4 gene.
After i.t. infection with 106 yeast cells, IL-4-depleted and
untreated mice were studied with regard to the severity of
infection in the lungs, liver, and spleen, the production of
specific isotypes, the levels of pulmonary and hepatic cyto-
kines, and pulmonary histopathologic findings. Surprisingly, an
exacerbation of pulmonary infection was observed in IL-4-
depleted B10.A mice, although only minor alterations in their
patterns of cellular immunity and humoral immunity were de-
tected. In contrast, PCM in IL-4-depleted C57BL/6 mice was
less severe than that in untreated mice and was associated with
decreased production of Th2 cytokines in association with en-
hanced levels of proinflammatory cytokines. As a whole, our
results demonstrated that IL-4 has a dual role in pulmonary
PCM and that its effects depend on the genetic background of
the host.
MATERIALS AND METHODS
Animals. Groups of five to seven male mice (8 to 11 weeks old) from strains
susceptible (B10.A) and intermediate (C57BL/6) to P. brasiliensis infection were
used for each period of infection. All of the animals were bred at University of
Sa˜o Paulo animal facilities under specific-pathogen-free conditions. Procedures
involving animals and their care were conducted in conformity with national and
international laws and policies.
Fungus. P. brasiliensis isolate 18 (Pb18), which is highly virulent, was used
throughout this study. To ensure the maintenance of its virulence, the isolate was
used after three serial animal passages (27). Pb18 yeast cells then were main-
tained by weekly subcultivation in a semisolid culture medium (20) at 35°C and
were used on day 7 of culturing. The fungal cells were washed in phosphate-
buffered saline (PBS [pH 7.2]) and counted in a hemocytometer, and the con-
centration was adjusted to 20  106 fungal cells ml1. The viability of fungal
suspensions, determined with Janus green B vital dye (Merck, Darmstadt, Ger-
many) (6), was always higher than 80%.
P. brasiliensis infection. Mice were anesthetized and infected i.t. with P. bra-
siliensis as previously described (17). Briefly, after i.p. anesthesia, the animals
were infected with 106 Pb18 yeast cells, contained in 50 l of PBS, by a surgical
i.t. inoculation that allowed dispensing of fungal cells directly into the lungs. The
skins of the mice were sutured, and the mice were allowed to recover under a
heat lamp.
Treatment of mice with an anti-IL-4 MAb. The anti-murine IL-4 hybridoma
11B11 (kindly provided by Robert Coffman, DNAX Research Institute, Palo
Alto, Calif.) was grown i.p. in Pristane (Sigma Chemical Co., St. Louis, Mo.)-
primed BALB/c athymic mice. The MAb was purified from ascites by using the
method of McKinney and Parkinson (32) and was assayed for purity by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. The biological activity of
MAb 11B11 was tested by measuring its activity as a capture antibody in a
previously standardized enzyme-linked immunosorbent assay (ELISA).
Two protocols were used to deplete endogenous IL-4. Groups of B10.A mice
were given 1 mg of MAb 11B11 or rat IgG (control) in 0.5 ml of PBS by the i.p.
route 1 day before i.t. inoculation with P. brasiliensis and 1.0 of MAb or rat IgG
weekly thereafter. These mice were studied 4 and 8 weeks after P. brasiliensis
infection. C57BL/6 mice were also depleted of IL-4 in vivo by weekly injection of
1 mg of MAb 11B11. Additional B10.A mice were injected i.p. with 8 mg of MAb
11B11 or rat IgG 1 day before infection and were studied 8 weeks later.
Assay for organ CFU. The numbers of viable microorganisms in the lungs,
liver, and spleen of experimental and control mice were determined by counting
the numbers of CFU. Animals from each group were sacrificed at adequate
intervals after infection, and enumeration of viable organisms in the three organs
was done as previously described (43). Briefly, aliquots (100 l) of cellular
suspensions and serial dilutions of samples from each organ were plated on brain
heart infusion agar (Difco) supplemented with 4% (vol/vol) horse serum (Insti-
tuto Butantan, Sa˜o Paulo, Brazil) and 5% Pb192 culture filtrate, the latter
constituting a source of growth-promoting factor. The plates were incubated at
35°C, and the colonies were counted daily until no increase in counts was
observed. The numbers (log10) of viable P. brasiliensis colonies per gram of tissue
were expressed as means and standard errors (SEs).
Histopathologic analysis. The left lung of each mouse was removed, fixed in
10% formalin, and embedded in paraffin. Five-micrometer sections were stained
with hematoxylin and eosin for analysis of lesions and stained with silver for
fungal evaluation. Pathologic findings were analyzed based on the number, size,
morphology, and cell composition of granulomatous lesions, the number of
fungi, and the intensity of inflammatory infiltrates.
Measurement of cytokines. Mice were infected i.t. with P. brasiliensis, and their
right lungs were removed aseptically and individually disrupted in 4.0 ml of
RPMI 1640 medium (Gibco BRL). Supernatants were separated from cell debris
by centrifugation at 2,000  g for 15 min, passed through 0.22-m-pore-size
filters (Millipore), and stored at 70°C. The levels of IL-2, IL-4, IL-5, IL-10,
IFN-, and IL-12 were measured by capture ELISAs with antibody pairs pur-
chased from Pharmingen (San Diego, Calif.). The concentrations of cytokines
were determined by reference to a standard curve for serial twofold dilutions of
murine recombinant cytokines. The lower limits of detection for the recombinant
standard curves were 32.0, 8.0, 7.0, 8.0, 20.0, and 15.0 pg/ml for IL-2, IL-4, IL-5,
IL-10, IFN-, and IL-12, respectively.
Measurement of serum P. brasiliensis-specific isotypes. Levels of specific iso-
types (total IgG, IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3) were measured by a
previously described ELISA (17) with a cell-free antigen (13) prepared from a
pool of various P. brasiliensis isolates (Pb339, Pb265, and Pb18). The average of
the optical densities obtained for sera collected from control mice (PBS inocu-
lated) and diluted 1:20 was considered the cutoff for each respective isotype.
Optical densities for each dilution of experimental sera were compared to con-
trol values. The titer for each sample was expressed as the reciprocal of the
highest dilution that resulted in an optical density higher than the cutoff.
Statistical analysis. Data from depletion experiments with 1 mg of MAb/week
were analyzed by parametric two-way analysis of variance followed by Tukey
comparisons (52). All other data were analyzed by unpaired Student’s t test. P
values of 0.05 were considered significant.
RESULTS
IL-4-depleted mice have increased pulmonary fungal loads.
With a view to determining whether the production of IL-4, a
Th2 cytokine, is responsible for progressive disease in suscep-
tible mice, IL-4-depleted B10.A mice were compared with
their counterparts in terms of their ability to control a P.
brasiliensis infection initiated by the respiratory route. Two
protocols were used to neutralize endogenous IL-4 in B10.A
mice. In a first experiment, IL-4 was depleted by weekly injec-
tions of 1 mg of an anti-IL-4 MAb, and organs were monitored
for fungal growth at weeks 4 and 8 after i.t. infection. Infected
B10.A mice inoculated with equivalent doses of normal rat IgG
were used as controls. Surprisingly, depletion of IL-4 with this
protocol increased the pulmonary fungal burden at week 4
after infection, but at week 8, equivalent numbers of viable
yeast cells were recovered from the lungs, liver, and spleen
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(Fig. 1). Since various investigators (23, 38) have demonstrated
the disease-promoting effect of IL-4 and since our protocol
could have induced only a partial depletion of IL-4, another
schedule was used to neutralize endogenous IL-4. Thus, an
additional group of B10.A mice was treated with 8 mg of MAb
at day 1 before infection and was studied 8 weeks later. Con-
firming the results of the first experiment, IL-4-depleted mice
had larger number of yeast cells in the lungs than did IgG-
treated controls (Fig. 2).
Since IL-4 was previously shown to be deleterious to
C57BL/6 mice (38), the 1 mg-per-week protocol was used in
this strain, and mice were assessed in terms of CFU at 8 weeks
after infection. Diminished numbers of fungal cells were de-
tected in the lungs of MAb-treated mice (Fig. 3). These results
showed that IL-4 plays different roles in pulmonary PCM. In
B10.A mice, IL-4 exerts a protective effect in the lungs, but its
neutralization in C57BL/6 mice leads to less severe disease at
the site of infection.
Depletion of IL-4 does not modify the morphology of pul-
monary lesions in B10.A mice but results in mild pathologic
changes in the lungs of C57BL/6 mice. Because of the earlier
observation of less severe lung pathologic changes in C57BL/6
FIG. 1. Effect of in vivo depletion of IL-4 (1 mg of anti-IL-4/week)
in B10.A mice infected i.t. with 106 P. brasiliensis yeast cells. The
recovery of CFU from the lungs, liver, and spleen of infected mice
treated with normal rat IgG (control) (white bars) or rat MAb 11B11
(1 mg/week) (stippled bars) is shown. The bars depict means and SEs
of log10 CFU obtained from groups of five to seven mice at weeks 4 and
8 after infection. Similar results were obtained in two separate exper-
iments. Data marked by an asterisk were significantly different (P 
0.05) from those for the control group.
FIG. 2. Effect of in vivo depletion of IL-4 (8 mg of anti-IL-4/week)
in B10.A mice infected i.t. with 106 P. brasiliensis (Pb) yeast cells. The
recovery of CFU from the lungs, liver, and spleen of infected mice
treated with normal rat IgG (control) or rat MAb 11B11 (8 mg 1 day
before infection) is shown. The bars depict means and SEs of log10
CFU obtained from groups of five to seven mice at week 8 after
infection. Data marked by an asterisk were significantly different (P 
0.05) from those for the control group.
FIG. 3. Effect of in vivo depletion of IL-4 in C57BL/6 mice infected
i.t. with 106 P. brasiliensis (Pb) yeast cells. The recovery of CFU from
the lungs, liver, and spleen of infected mice treated with normal rat
IgG (control) or rat MAb 11B11 (1 mg/week) is shown. The bars depict
means and SEs of log10 CFU obtained from groups of five to seven
mice at week 8 after infection. Data marked by an asterisk were
significantly different (P  0.05) from those for the control group.
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mice with a disruption of the IL-4 gene (38), we compared
pulmonary lesions in IL-4-depleted B10.A and C57BL/6 mice
with those in their IgG-treated control counterparts. The le-
sions that developed in IL-4-depleted B10.A mice (Fig. 4B)
were equivalent to those in IgG-treated mice (Fig. 4A). The
pulmonary lesions in both groups were poorly organized, ran-
domly distributed, and composed of isolated or confluent gran-
ulomas of various sizes and containing many fungal cells sur-
rounded by macrophages, lymphocytes, and plasma cells.
Confluent or isolated lesions in control C57BL/6 mice (Fig.
4C) were more organized than those in B10.A mice and were
circumscribed by an evident mantle of small lymphocytes. Less
intense results were seen in IL-4-depleted C57BL/6 mice (Fig.
4D): the lesions were smaller, better organized, and infiltrated
with a diminished number of inflammatory cells, causing a
milder disruption of the pulmonary parenchyma.
IL-4 depletion does not alter pulmonary cytokine produc-
tion in B10.A mice but induces decreased Th2 responses in
C57BL/6 mice. Since IL-4 depletion led to different results in
the pulmonary disease seen in B10.A and C57BL/6 mice, we
examined whether these results were associated with different
patterns of pro- and anti-inflammatory cytokines in infected
organs. First, we characterized the production of IFN-, IL-2,
and IL-12 and the production of IL-4, IL-5, and IL-10 in
homogenates of lung samples from IL-4-depleted B10.A mice.
Neutralization of IL-4 with 1 mg of MAb/week did not change
the amounts of Th1 and Th2 cytokines present in the lungs of
mice at weeks 4 and 8 after infection (Fig. 5). The administra-
tion of a high dose (8 mg) of anti-IL-4 MAb 1 day before
infection also did not alter the amounts of both types of cyto-
kines (Fig. 6).
Since IL-4-depleted C57BL/6 mice developed less intense
disease and inflammatory reactions in the lungs, we extended
our cytokine study to include the quantification of tumor ne-
crosis factor alpha (TNF-) in the lungs and liver. Figures 7
and 8 demonstrate that, indeed, the neutralization of endoge-
nous IL-4 in C57BL/6 mice caused decreased production of
Th2 cytokines (IL-5 in the lungs and IL-4 and IL-5 in the liver).
This finding was associated with increased production of proin-
flammatory cytokines (TNF- in the lungs and IL-12 in the
liver). However, an evident shift to a Th1 immune response
was not detected, since the production of IFN- and IL-2,
typical Th1 cytokines, did not change in anti-IL-4 MAb-treated
mice.
Depletion of IL-4 does not modify the humoral immune
response of B10.A mice but alters the levels of IgG1 and IgG2a
isotypes in C57BL/6 mice. Since IL-4 is the principal cytokine
that stimulates B-cell heavy-chain class switching to the IgE
FIG. 4. Photomicrographs of pulmonary lesions from B10.A (A and B) and C57BL/6 (C and D) mice. Animals were depleted of IL-4 in vivo
with an anti-IL-4 MAb (1 mg/week) (B and D) or received control normal rat IgG (A and C). Control and anti-IL-4 treated mice were infected
i.t. with 106 P. brasiliensis yeast cells and studied at week 8 of infection. At this time, no differences in the lesions of treated and untreated B10.A
mice were noted, but the granulomatous inflammation was more extensive and confluent in control C57BL/6 mice than in IL-4-depleted mice.
Hematoxylin-eosin stain was used; the magnifciation was 100.
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and IgG1 isotypes and inhibits IFN--stimulated switching to
the IgG2a isotype in mice (44, 45), we examined whether IL-4
depletion would influence isotype production in B10.A and
C57BL/6 mice differently. Confirming the CFU and cytokine
data, both schedules of IL-4 depletion did not change the levels
of any studied isotypes in B10.A mice (Fig. 9). However, IgG1
antibodies were synthesized at lower levels by IL-4-depleted
C57BL/6 mice than by untreated control mice. Conversely,
IgG2a was detected at higher levels in the serum of IL-4-
depleted C57BL/6 mice.
DISCUSSION
This work showed that IL-4 could exert different roles in
pulmonary PCM depending on the genetic pattern of the host.
Depletion of IL-4 in genetically susceptible B10.A mice led to
increased pulmonary fungal burdens, whereas PCM in
C57BL/6 mice (intermediate susceptibility to P. brasiliensis)
depleted in vivo of endogenous IL-4 was less severe and was
associated with the increased production of TNF- and IL-12
and with the diminished secretion of IL-4 and IL-5. The ex-
periments with IL-4 depletion showed that the susceptibility of
B10.A mice to P. brasiliensis is not governed mainly by IL-4.
This result is different from those obtained with other systemic
mycoses, such as candidiasis, histoplasmosis, and coccidioid-
omycosis, where in vivo depletion of IL-4 induced immuno-
protection and allowed the development of Th1 rather than
Th2 immune responses (29, 39, 53).
The increased pulmonary CFU numbers detected in IL-4-
depleted B10.A mice were not accompanied by marked differ-
ences in lung histopathologic findings, the presence of various
cytokines in lung homogenates, and humoral immune re-
sponses. It can be argued that IL-4 depletion was not efficient,
since no differences in immune responses were noted. How-
ever, neutralization of IL-4 increased pulmonary fungal bur-
dens, demonstrating that the MAb in some way reached or
influenced the behavior of the lungs. One possible explanation
for this result is that IL-4 is not the main mediator that governs
susceptibility to pulmonary PCM in B10.A mice. Other cyto-
kines, such as IL-10 and transforming growth factor , are
under investigation in our laboratories. Indeed, PCM in
C57BL/6 IL-10 knockout mice is less severe than that in con-
trol mice with normal IL-10 and, at week 8 after infection, the
lungs of IL-10-deficient mice show almost no pathologic
changes compared to those of control mice (T. Alves and
V. L. G. Calich, unpublished results). Other immunological
mechanisms could be ascribed to the susceptibility of B10.A
mice. It was recently demonstrated that nitric oxide is an im-
portant molecule associated with both immunoprotection, by
FIG. 5. IL-4 depletion by treatment with 1 mg of anti-IL-4 MAb/week does not alter Th1 and Th2 cytokines of B10.A mice. At 4 and 8 weeks
after P. brasiliensis (Pb) infection, lungs were collected from IL-4-depleted and control B10.A mice and disrupted in 4.0 ml of RPMI 1640 medium.
Supernatants were analyzed for cytokine contents by a capture ELISA. The bars depict means and SEs of cytokine levels for five or six mice.
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enhancing the clearance of fungal cells, and immunosuppres-
sion developed in B10.A mice. When challenged by P. brasil-
iensis yeast cells, macrophages from susceptible B10.A mice
secreted large amounts of nitric oxide, whereas those from
resistant A/Sn mice secreted TNF-. The impaired production
of TNF- by macrophages from B10.A mice was reversed by
drugs that inhibit nitric oxide production (36). Additional find-
ings indicate that B10.A susceptibility is not governed by CD4
Th2 responses; in vivo depletion of CD4 T cells does not
abolish the progressive nature of the disease, and the relative
immunoprotection developed by this strain of mice is mediated
by IFN--secreting CD8 T cells (8).
The increased fungal burdens detected in IL-4-depleted
mice are not totally unexpected. Indeed, Flesh and Kaufmann
(21) described increased bacteriostactic activity of IL-4-treated
macrophages. Furthermore, IL-4 has been reported to en-
hance murine macrophage mannose receptor activity (47) and
to stimulate phagocytosis and microbial killing by neutrophils
(7) and macrophages (51). In other experimental models of
immunoprotection, IL-4 was also found to be important in
controlling pathology. Thus, IL-4 is a protective cytokine
against tumor cells (41, 50), adenoviruses (18), mycobacteria
(48), and Trypanosoma brucei (24), among others. In an ele-
gant study, Mencacci et al. (33) also demonstrated a dual role
for IL-4 in murine candidiasis. IL-4-deficient mice were more
resistant to early Candida albicans infection but failed to
mount a protective Th1 immune response in the late phase and
succumbed due an impaired ability to produce sufficient
amounts of IFN- and IL-12.
In contrast to the findings obtained with B10.A mice, the
results obtained with IL-4-depleted C57BL/6 mice demon-
strated the therapeutic effect of IL-4 neutralization and are
consistent with the results obtained by Hostetler et al. (23)
showing the deleterious role of IL-4 in murine PCM of
BALB/c mice. Altogether, these data clearly show the influ-
ence of the genetic background on the effect of endogenous
IL-4 and demonstrate that different mechanisms can account
for host susceptibility to PCM. The diminished numbers of
viable yeast cells recovered from the lungs of IL-4-depleted
C57BL/6 mice were concomitant with a diminished Th2 im-
mune response, as revealed by decreased levels of IL-5 in the
lungs and IL-5 and IL-4 in the liver. The less severe disease was
associated with the increased production of TNF- in the lungs
and IL-12 in the liver of IL-4 depleted mice. The decreased
fungal loads observed could have been ascribed, at least par-
tially, to cytokines that were previously shown to be immuno-
protective against murine PCM (19, 36, 46). Another promi-
nent feature of PCM in IL-4-depleted mice was the less severe
lung pathologic changes, where well-organized granulomas
FIG. 6. IL-4 depletion by treatment with 8 mg of anti-IL-4 MAb 1
day before infection does not alter Th1 and Th2 cytokines of B10.A
mice. At 8 weeks after P. brasiliensis (Pb) infection, lungs were col-
lected from IL-4-depleted and control B10.A mice and disrupted in 4.0
ml of RPMI 1640 medium. Supernatants were analyzed for cytokine
contents by a capture ELISA. The bars depict means and SEs of
cytokine levels for five or six mice.
FIG. 7. IL-4 depletion induces the production of higher levels of
TNF- and diminished levels of IL-5 in the lungs of C57BL/6 mice. At
8 weeks after i.t. infection with 106 yeast cells of P. brasiliensis (Pb),
lungs were collected from IL-4-depleted and control mice and dis-
rupted in 4.0 ml of RPMI 1640 medium. Supernatants were analyzed
for cytokine contents by a capture ELISA. The bars depict means and
SEs of cytokine levels for four or five animals per group. Data marked
by an asterisk were significantly different (P  0.05) from those for the
control group.
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containing yeast cells circumscribed by small numbers of in-
flammatory leukocytes replaced the more exuberant inflamma-
tory reactions developed by control mice. This inflammatory
architecture appears to be highly efficient in avoiding fungal
growth outside the center of the lesion. The increased produc-
tion of TNF- detected locally in the lungs appeared to con-
tribute to this type of lesion, since in previous studies with
TNF- receptor knockout mice, the focal granulomatous re-
action developed by control wild-type C57BL/6 mice was sub-
stituted by a nonorganized inflammatory exudate that de-
stroyed the normal lung parenchyma. We can speculate that in
IL-4-depleted mice, the increased production of TNF- and its
stimulatory activity on phagocytes for fungal killing contrib-
uted to the immunological control of P. brasiliensis growth.
The humoral immune response to P. brasiliensis did not
change after depletion of IL-4 in B10.A mice with 1 mg of
MAb/week. It can be argued that the amount of MAb used was
not sufficient to inhibit the B-cell-activating function of IL-4.
However, even with 8 mg of MAb at day 1 before infection, no
differences were noted in antibody production. Thus, for PCM
in B10.A mice, the residual activity of IL-4 could be sufficient
to regulate antibody production or this cytokine could be re-
placed by another mediator, such as IL-13, whose activity is
similar to that of IL-4. This situation is not unusual, and in a
murine model of granulomas induced by Schistosoma mansoni
eggs, the use of IL-4 and IL-13 double knockout mice clarified
the cooperative and overlapping actions of IL-4 and IL-13 in
initiating Th2 cell-driven responses (31). In parallel with de-
creased levels of Th2 cytokines (IL-4 and IL-5), smaller
amounts of IgG1 antibodies were secreted by IL-4-depleted
C57BL/6 mice than by untreated control mice. The increased
titers of IgG2a could have been due to the maintained secre-
tion of IFN-, a well-characterized IgG2a switching factor (44,
45) associated with decreased levels of Th2 cytokines. Similar
alterations of IgG1 and IgG2a antibodies were obtained in
C57BL/6 IL-4 knockout mice compared with their wild-type
control counterparts (38).
Overlapping functions of several mediators of immune re-
sponses and their different manifestations in the context of
different genetic backgrounds have been described. Indeed, in
a study of resistance to infection with Trichuris muris, it was
FIG. 8. IL-4 depletion induces the production of higher levels of
IL-12 and diminished levels of IL-5 and IL-4 in the livers of C57BL/6
mice. At 8 weeks after i.t. infection with 106 yeast cells of P. brasiliensis
(Pb), livers from IL-4-depleted and control mice were collected and
disrupted in 4.0 ml of RPMI 1640 medium. Supernatants were ana-
lyzed for cytokine contents by a capture ELISA. The bars depict means
and SEs of cytokine levels for four or five animals per group. Data
marked by an asterisk were significantly different (P 0.05) from those
for the control group.
FIG. 9. Levels of P. brasiliensis (Pb)-specific antibodies in sera of
IL-4-depleted and control B10.A (A) and C57BL/6 (B) mice at week 8
after i.t. infection with 106 yeast cells. Sera were assayed for total
immunoglobulin, IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3 by using an
isotype-specific ELISA as detailed in Materials and Methods. The bars
depict means (log2) and SEs of serum titers for five to eight mice per
group. Data marked by an asterisk were significantly different (P 
0.05) from those for the control group.
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demonstrated that IL-4 knockout mice in a C57BL/6 back-
ground were susceptible, whereas IL-4 knockout mice in a
BALB/c background were resistant (4). Similar findings have
been described for the development of hapten-induced contact
hypersensitivity. IL-4 played an important role in the onset of
hapten-induced reactions in BALB/c mice but not in C57BL/6
mice (35).
As a whole, our results demonstrated that IL-4 is an impor-
tant cytokine that can modulate positively or negatively the
patterns of susceptibility of hosts to P. brasiliensis infection.
The antagonistic effects of IL-4 in hosts of different genetic
backgrounds demonstrate that several immunological mecha-
nisms can lead to susceptibility to pulmonary infection by P.
brasiliensis and, more than that, the Th1-Th2 paradigm does
not explain all of the immunological mechanisms that deter-
mine disease outcome. Our findings also open new perspec-
tives for analyzing and trying to understand the behavior of the
severe form of the disease in many patients who do not show
an immune response polarized to the Th2 pattern. Consistent
with our findings, a recent study showed that Fas-Fas ligand
(CD95-CD95L) and cytotoxic T-lymphocyte antigen 4 (CTLA-
4) engagement is an important mechanism associated with
T-cell unresponsiveness in patients with severe PCM (14).
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